Valuation: Principal Technologies Inc.

Market Cap 1.81Cr 1.27Cr 1.13Cr 1.05Cr 95.86L 121.92Cr 1.82Cr 13Cr 4.93Cr 62Cr 4.76Cr 4.66Cr 200.03Cr P/E 2024 *
-
P/E 2025 -2x
Enterprise Value 1.71Cr 1.2Cr 1.06Cr 99.34L 90.54L 115.15Cr 1.72Cr 12Cr 4.66Cr 59Cr 4.5Cr 4.4Cr 188.93Cr EV / Sales 2024
71,72,726x
EV / Sales 2025 2,52,90,400x
Free-Float
66.21%
Yield 2024 *
-
Yield 2025 -
3 years 0
Extreme 0
0.27
5 years 0
Extreme 0
0.27
10 years 0
Extreme 0
0.27
Manager TitleAgeSince
Chief Executive Officer 47 04/08/2021
Director of Finance/CFO 70 06/03/2023
Director TitleAgeSince
Director/Board Member 70 04/08/2021
Chairman 55 -
Director/Board Member 47 04/08/2021
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 1.35Cr
+4.16%+3.04%+49.37%+94.17% 7.44TCr
-3.11%-2.32%+23.28%+77.03% 5.93TCr
+0.89%-0.77%+5.80%+32.89% 4.71TCr
-0.96%-4.50%+26.36%+33.18% 4.29TCr
+0.36%+0.81%+352.17%+689.61% 4.41TCr
-0.20%-0.77%+3.74%+100.60% 4.08TCr
-0.54%+2.93%+9.50%+50.41% 3.08TCr
-2.68%+5.11%+33.11%+19.50% 2.93TCr
+2.33%-5.69%-27.28%+338.00% 2.37TCr
Average +0.03%-0.64%+52.89%+159.49% 4.36TCr
Weighted average by Cap. +0.25%-0.40%+58.02%+150.90%

Financials

2024 2025
Net sales 0.66 0.47 0.41 0.39 0.35 44.78 0.67 4.67 1.81 22.89 1.75 1.71 73.47 0.37 0.26 0.23 0.22 0.2 24.98 0.37 2.61 1.01 12.77 0.98 0.95 40.98
Net income -16.15L -11.33L -10.07L -9L -9L -11Cr -16.3L -1.14Cr -44.06L -5.57Cr -42.54L -41.61L -18Cr -42.35L -29.71L -26.4L -24.64L -22.46L -29Cr -42.75L -2.98Cr -1.16Cr -15Cr -1.12Cr -1.09Cr -47Cr
Net Debt -8L -5L -5L -4L -4L -5.18Cr -8L -54.03L -20.93L -2.65Cr -20.21L -19.77L -8.49Cr -10.03L -7L -6L -6L -5L -6.76Cr -10.12L -70.61L -27.36L -3.46Cr -26.42L -25.84L -11Cr
Logo Principal Technologies Inc.
Principal Technologies Inc. is a Canada-based healthcare acquisition company. The Company is engaged in building a diverse portfolio of investments in healthcare technology companies with a focus on those with global distribution potential which have intellectual property capable of enhancing medical treatment quality, cost efficiency, optimization of the patient pathway, and implementation of point of care technologies. The Company operates through the health-care technology segment, including the project management of international scale clinical studies primarily related to medical device technologies. Its subsidiaries include Principal Technologies Capital Management GmbH and E&E CRO Consulting GmbH.
Employees
-